Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Prognosis of Patients with Metastatic Spinal Cord Compression from Adrenocortical Carcinoma

STEFAN JANSSEN, TOBIAS BARTSCHT and DIRK RADES
In Vivo September 2016, 30 (5) 717-719;
STEFAN JANSSEN
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOBIAS BARTSCHT
2Department of Hematology & Oncology, University of Lübeck, Lübeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rades.dirk@gmx.net
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Adrenocortical cancer is a rare aggressive type of cancer. The prognosis is poor, particularly for metastatic disease. This study focused on metastatic spinal cord compression (MSCC) from adrenocortical carcinoma. Patients and Methods: Data of three patients who received palliative irradiation of MSCC from adrenocortical carcinoma were retrospectively analyzed for motor function, ambulatory status and survival. Results: One patient died before completion of radiotherapy. The other two patients died two weeks and four weeks, respectively, following irradiation. In these patients, pre-radiotherapy pain scores were 9 and 10 points. In both patients, partial pain relief was achieved (scores of 5 and 4 points). All three patients were non-ambulatory before irradiation. In assessable patients, motor function remained unchanged following irradiation. Conclusion: Palliative irradiation resulted in considerable pain relief, whereas motor function did not improve. Considering the extremely poor survival, supportive care alone may be considered if pain relief is achieved without irradiation.

  • Adrenocortical carcinoma
  • metastatic spinal cord compression
  • palliative irradiation
  • best supportive care
  • treatment results

Adrenocortical cancer is a rare and very aggressive type of cancer (1-4) with, generally, poor prognosis, in particular in cases of distant metastases. Adrenocortical cancer can metastasize to the bone, including vertebral bodies. A complication of vertebral body metastases is metastatic spinal cord compression (MSCC) (5, 6). Since adrenocortical cancer is a rare disease, very little is known on MSCC from this type of cancer. Several treatment options are available for this situation, such as palliative irradiation, decompressive surgery followed by irradiation and best supportive care alone, including administration of dexamethasone (7-9). The present study presents a small series of patients with MSCC from adrenocortical carcinoma and aims to contribute to the appropriate treatment for this rare oncological situation.

Patients and Methods

The data of three patients who received palliative irradiation for MSCC from adrenocortical carcinoma were analyzed in this retrospective study with respect to the treatment effect on motor function and ambulatory status, as well as with respect to survival. Median age was 64 years (range=51-65). Additional characteristics of the patients are given in Table I.

Pain was evaluated before and at the end of the radiotherapy course with a scale between 0 points (no pain) and 10 points (maximum pain). Partial response was defined as improvement of at least two points and complete response as 0 points. Motor function was also evaluated before and after irradiation with a five-category scale: 0, normal strength; 1, ambulation without aid; 2, ambulation with aid; 3, patient not ambulatory; 4, complete paraplegia (10). Improvement and deterioration of motor function were rated as a change of one or more categories. Survival time, given in weeks, was counted from the last day of irradiation.

Results

Of the three patients, one patient died before the radiotherapy course was completed. The other two patients died two weeks and four weeks, respectively, following irradiation, resulting in a median survival time of two weeks. Thus, only two patients were assessable for pain relief and treatment effect on motor function. In these two patients, pre-radiotherapy pain scores were 9 and 10 points, respectively. In both patients, partial pain relief was achieved with post-irradiation pain scores of 5 and 4 points, respectively. All three patients were not able to walk before irradiation (category 3 on the five-category scale). In the two assessable patients, motor function remained unchanged following irradiation. Thus, no patient regained the ability to walk.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Patients' characteristics.

Discussion

Since most patients with adrenocortical carcinoma have a poor prognosis, there is a constant interest of research in the improvement of the patients' prognoses (1-4). This applies also to patients who have already developed distant metastases. MSCC occurs in up to 10% of all adult cancer patients (11-16). Patients with MSCC from adrenocortical carcinoma represent a small group of patients with MSCC accounting for about 0.1% of all MSCC patients. Therefore, only very little is known on this particular group of cancer patients. The present study is the first reported so far that focused on patients with MSCC from adrenocortical carcinoma. It aimed to contribute to the appropriate treatment of these patients. Since MSCC from adrenocortical carcinoma is an extremely rare situation, only three patients could be included in this study. The very small sample size and the retrospective design of the study should be kept in mind during the interpretation of the results.

Despite the small number of patients, this study provided interesting results. Palliative irradiation resulted in partial pain relief and can, therefore, be of benefit for those patients experiencing severe vertebral bone pain. In contrast, palliative irradiation failed to improve motor function and ambulatory status. This may be explained with a reduced radio-sensitivity of adrenocortical carcinoma or by the fact that no patient survived longer than four weeks following irradiation (5, 6). Previous studies have shown that a positive effect of radiotherapy on motor function takes at least one month in many patients irradiated for MSCC (5, 12, 16). Taking into account the extremely poor survival prognosis of patients with MSCC from adrenocortical carcinoma observed in this study, it appears that these patients do not benefit from palliative irradiation in terms of improvement in motor function and ambulatory status. Thus, palliative irradiation may be limited to those patients requiring pain relief. If sufficient pain relief can be achieved with analgesic drugs, best supportive care alone appears an appropriate option.

In conclusion, palliative irradiation resulted in considerable pain relief in patients with MSCC from adrenocortical carcinoma. In contrast, motor function and ambulatory status did not improve. Thus, taking into account the extremely poor survival of these patients, supportive care alone may be considered if pain relief is not the indication for palliative irradiation.

Footnotes

  • Conflicts of Interest

    On behalf of all Authors, the corresponding Author states that there are no conflicts of interest related to this study.

  • Received June 5, 2016.
  • Revision received June 24, 2016.
  • Accepted June 27, 2016.
  • Copyright © 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Bacalbasa N,
    2. Terzea D,
    3. Jianu V,
    4. Marcu M,
    5. Stoica C,
    6. Balescu I
    : Multiple visceral resection for giant non-secretory adrenocortical carcinoma in an elderly patient: a case report. Anticancer Res 35: 2169-2174, 2015.
    OpenUrlAbstract/FREE Full Text
    1. Alanee S,
    2. Dynda D,
    3. Holland B
    : Prevalence and prognostic value of lymph node dissection in treating adrenocortical carcinoma: A national experience. Anticancer Res 35: 5575-5579, 2015.
    OpenUrlAbstract/FREE Full Text
    1. Zeng W,
    2. Chen X,
    3. Ma Y,
    4. Huang Z,
    5. Qin Y,
    6. Wu F,
    7. Wu L,
    8. Liang X,
    9. Qin Y,
    10. Zhou J,
    11. Lu D,
    12. Kuang X,
    13. Li QQ,
    14. Luo Z
    : A novel approach for enriching cancer stem cells from the human SW-13 adrenocortical carcinoma cell line. Anticancer Res 34: 117-123, 2014.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Mege D,
    2. Taieb D,
    3. Lowery A,
    4. Loundou A,
    5. DE Micco C,
    6. Castinetti F,
    7. Morange I,
    8. Henry JF,
    9. Sebag F
    : Contemporary review of large adrenal tumors in a tertiary referral center. Anticancer Res 34: 2581-2588, 2014.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    1. Rades D,
    2. Abrahm JL
    : The role of radiotherapy for metastatic epidural spinal cord compression. Nat Rev Clin Oncol 7: 590-598, 2010.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Prasad D,
    2. Schiff D
    : Malignant spinal cord compression. Lancet Oncol 6: 15-24, 2005.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Rades D,
    2. Huttenlocher S,
    3. Bajrovic A,
    4. Karstens JH,
    5. Adamietz IA,
    6. Kazic N,
    7. Rudat V,
    8. Schild SE
    : Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. Int J Radiat Oncol Biol Phys 81: e861-868, 2011.
    OpenUrlCrossRefPubMed
    1. Rades D,
    2. Huttenlocher S,
    3. Dunst J,
    4. Bajrovic A,
    5. Karstens JH,
    6. Rudat V,
    7. Schild S
    : Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. J Clin Oncol 28: 3597-3604, 2010.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Patchell R,
    2. Tibbs PA,
    3. Regine WF,
    4. Payne R,
    5. Saris S,
    6. Kryscio RJ,
    7. Mohiuddin M,
    8. Young B
    : Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 366: 643-648, 2005.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Tomita T,
    2. Galicich JH,
    3. Sundaresan N
    : Radiation therapy for spinal epidural metastases with complete block. Acta Radiol Oncol 22: 135-143, 1983.
    OpenUrlPubMed
  8. ↵
    1. Rades D,
    2. Conde-Moreno AJ,
    3. Garcia R,
    4. Veninga T,
    5. Schild SE
    : A tool to estimate survival of elderly patients presenting with metastatic epidural spinal cord compression (MESCC) from cancer of unknown primary. Anticancer Res 35: 6219-6222, 2015.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Rades D,
    2. Huttenlocher S,
    3. Schild SE,
    4. Bartscht T
    : Metastatic spinal cord compression from pancreatic cancer. Anticancer Res 34: 3727-3730, 2014.
    OpenUrlAbstract/FREE Full Text
    1. Rades D,
    2. Conde-Moreno AJ,
    3. Cacicedo J,
    4. Segedin B,
    5. Veninga T,
    6. Schild SE
    : Metastatic spinal cord compression: A survival score particularly developed for elderly prostate cancer patients. Anticancer Res 35: 6189-6192, 2015.
    OpenUrlAbstract/FREE Full Text
    1. Rades D,
    2. Schild SE,
    3. Karstens JH,
    4. Hakim SG
    : Predicting survival of patients with metastatic epidural spinal cord compression from cancer of the head-and-neck. Anticancer Res 35: 385-388, 2015.
    OpenUrlAbstract/FREE Full Text
    1. Rades D,
    2. Evers JN,
    3. Bajrovic A,
    4. Veninga T,
    5. Schild SE
    : Re-irradiation of spinal cord compression due to metastasis in elderly patients. Anticancer Res 34: 2555-2558, 2014.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Rades D,
    2. Dahlke M,
    3. Janssen S,
    4. Gebauer N,
    5. Bartscht T
    : Radiation therapy for metastatic spinal cord compression in patients with hepatocellular carcinoma. In Vivo 29: 749-752, 2015.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

In Vivo: 30 (5)
In Vivo
Vol. 30, Issue 5
September-October 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prognosis of Patients with Metastatic Spinal Cord Compression from Adrenocortical Carcinoma
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Prognosis of Patients with Metastatic Spinal Cord Compression from Adrenocortical Carcinoma
STEFAN JANSSEN, TOBIAS BARTSCHT, DIRK RADES
In Vivo Sep 2016, 30 (5) 717-719;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Prognosis of Patients with Metastatic Spinal Cord Compression from Adrenocortical Carcinoma
STEFAN JANSSEN, TOBIAS BARTSCHT, DIRK RADES
In Vivo Sep 2016, 30 (5) 717-719;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Prognostic Factors and a Survival Score in Patients Irradiated for Metastatic Epidural Spinal Cord Compression from Urothelial Carcinoma Cancer of the Bladder
  • Outcomes After Radiotherapy Alone for Metastatic Spinal Cord Compression in Patients with Oligo-metastatic Breast Cancer
  • Predicting the Ambulatory Status of Patients Irradiated for Metastatic Spinal Cord Compression (MSCC) from Head-and-neck Cancer
  • Comparison of Two Radiotherapy Regimens for Metastatic Spinal Cord Compression: Subgroup Analyses from a Randomized Trial
  • Predictive Factors and a Survival Score for Patients Irradiated for Metastatic Spinal Cord Compression from Carcinoma of the Salivary Glands
  • Google Scholar

More in this TOC Section

  • Preferences Regarding Breast Surgery Omission Among Patients With Breast Cancer Who Receive Neoadjuvant Chemotherapy
  • Forensic Medical Examination After Sexual Violence: Implications Based on Victims’ Perceptions
  • Albumin–derived Neutrophil-to-Lymphocyte Ratio Score as a Marker of Nivolumab Treatment Sensitivity in Gastric Cancer: A Multicenter Study
Show more Clinical Studies

Similar Articles

Keywords

  • Adrenocortical carcinoma
  • metastatic spinal cord compression
  • palliative irradiation
  • best supportive care
  • treatment results
In Vivo

© 2023 In Vivo

Powered by HighWire